Erschienen in:
09.06.2017 | Endocrine Tumors
Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting
verfasst von:
Hyemi Kwon, MD, Min Ji Jeon, MD, PhD, Won Gu Kim, MD, PhD, Suyeon Park, MD, Mijin Kim, MD, Tae Yong Kim, MD, PhD, Minkyu Han, PhD, Dong Eun Song, MD, PhD, Tae-Yon Sung, MD, PhD, Jong Ho Yoon, MD, PhD, Suck Joon Hong, MD, PhD, Jin-Sook Ryu, MD, PhD, Young Kee Shong, MD, PhD, Won Bae Kim, MD, PhD
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 9/2017
Einloggen, um Zugang zu erhalten
Abstract
Background
Most of the increase in thyroid cancer in recent decades has been due to papillary thyroid microcarcinoma (PTMC). We evaluated the efficacy of radioiodine remnant ablation (RRA) in patients with PTMC.
Methods
This historical cohort study included 1932 PTMC patients without lateral cervical lymph node (LN) or distant metastasis who underwent total thyroidectomy (TT) during the median 8.3 years of follow-up. The clinical outcomes of patients with or without RRA were compared using weighted logistic regression models with the inverse probability of treatment weighting (IPTW) method and considering risk factors, including age, sex, primary tumor size, extrathyroidal extension, multifocality, and central cervical LN metastasis.
Results
The median primary tumor size of the RRA group was significantly larger than that of the no-RRA group (0.7 vs. 0.5 cm, P < 0.001). There were significantly more patients with multifocality, extrathyroidal extension, and cervical LN metastasis in the RRA group compared with the no-RRA group. There was no significant difference in recurrence-free survival between the two groups (P = 0.11). Cox proportional–hazard analysis with IPTW by adjusting for clinicopathological risk factors demonstrated no significant difference in recurrence of PTMC according to RRA treatment (hazard ratio [HR] 2.02; 95% confidence interval [CI] 0.65–6.25; P = 0.2).
Conclusions
RRA had no therapeutic effect on the clinical outcomes of patients with PTMC who underwent TT. Surgical treatment without RRA could be applicable for patients with PTMC if there is no evidence of lateral cervical LN metastasis or distant metastasis.